BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22022569)

  • 1. Endoplasmic reticulum quality control is involved in the mechanism of endoglin-mediated hereditary haemorrhagic telangiectasia.
    Ali BR; Ben-Rebeh I; John A; Akawi NA; Milhem RM; Al-Shehhi NA; Al-Ameri MM; Al-Shamisi SA; Al-Gazali L
    PLoS One; 2011; 6(10):e26206. PubMed ID: 22022569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoglin mutants retained in the endoplasmic reticulum exacerbate loss of function in hereditary hemorrhagic telangiectasia type 1 (HHT1) by exerting dominant negative effects on the wild type allele.
    Gariballa N; Badawi S; Ali BR
    Traffic; 2024 Jan; 25(1):e12928. PubMed ID: 38272447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of endoglin mutations from hereditary hemorrhagic telangiectasia type 1 patients reveals different mechanisms for endoglin loss of function.
    Mallet C; Lamribet K; Giraud S; Dupuis-Girod S; Feige JJ; Bailly S; Tillet E
    Hum Mol Genet; 2015 Feb; 24(4):1142-54. PubMed ID: 25312062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention in the endoplasmic reticulum is the underlying mechanism of some hereditary haemorrhagic telangiectasia type 2 ALK1 missense mutations.
    Hume AN; John A; Akawi NA; Al-Awadhi AM; Al-Suwaidi SS; Al-Gazali L; Ali BR
    Mol Cell Biochem; 2013 Jan; 373(1-2):247-57. PubMed ID: 23124896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ENG mutation causing impaired co-translational processing of endoglin associated with hereditary hemorrhagic telangiectasia.
    Suzuki A; Nakashima D; Miyawaki Y; Fujita J; Maki A; Fujimori Y; Takagi A; Murate T; Teranishi M; Matsushita T; Saito H; Kojima T
    Thromb Res; 2012 May; 129(5):e200-8. PubMed ID: 22385575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia.
    Llorca O; Trujillo A; Blanco FJ; Bernabeu C
    J Mol Biol; 2007 Jan; 365(3):694-705. PubMed ID: 17081563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.
    Abdalla SA; Letarte M
    J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis.
    Lenato GM; Suppressa P; Giordano P; Guanti G; Guastamacchia E; Triggiani V; Amati L; Resta F; Covelli V; Jirillo E; Sabbà C
    Curr Pharm Des; 2007; 13(36):3656-64. PubMed ID: 18220803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.
    Berg J; Porteous M; Reinhardt D; Gallione C; Holloway S; Umasunthar T; Lux A; McKinnon W; Marchuk D; Guttmacher A
    J Med Genet; 2003 Aug; 40(8):585-90. PubMed ID: 12920067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.
    Harrison RE; Flanagan JA; Sankelo M; Abdalla SA; Rowell J; Machado RD; Elliott CG; Robbins IM; Olschewski H; McLaughlin V; Gruenig E; Kermeen F; Halme M; Räisänen-Sokolowski A; Laitinen T; Morrell NW; Trembath RC
    J Med Genet; 2003 Dec; 40(12):865-71. PubMed ID: 14684682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia.
    Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K
    Microvasc Res; 2015 May; 99():118-26. PubMed ID: 25892364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
    Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
    Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary haemorrhagic telangiectasia: a clinical and scientific review.
    Govani FS; Shovlin CL
    Eur J Hum Genet; 2009 Jul; 17(7):860-71. PubMed ID: 19337313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasia.
    Lee NP; Matevski D; Dumitru D; Piovesan B; Rushlow D; Gallie BL
    J Med Genet; 2011 May; 48(5):353-7. PubMed ID: 21415079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT).
    Ojeda-Fernandez L; Barrios L; Rodriguez-Barbero A; Recio-Poveda L; Bernabeu C; Botella LM
    Clin Chim Acta; 2010 Apr; 411(7-8):494-9. PubMed ID: 20067780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1.
    Pece-Barbara N; Cymerman U; Vera S; Marchuk DA; Letarte M
    Hum Mol Genet; 1999 Nov; 8(12):2171-81. PubMed ID: 10545596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic analyses of three Korean families with hereditary hemorrhagic telangiectasia.
    Kim MJ; Kim ST; Lee HD; Lee KY; Seo J; Lee JB; Lee YJ; Oh SP
    BMC Med Genet; 2011 Oct; 12():130. PubMed ID: 21967607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary Haemorrhagic Telangiectasia (HHT): genetic and molecular aspects.
    Lenato GM; Guanti G
    Curr Pharm Des; 2006; 12(10):1173-93. PubMed ID: 16611099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations.
    Prigoda NL; Savas S; Abdalla SA; Piovesan B; Rushlow D; Vandezande K; Zhang E; Ozcelik H; Gallie BL; Letarte M
    J Med Genet; 2006 Sep; 43(9):722-8. PubMed ID: 16690726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype.
    Bossler AD; Richards J; George C; Godmilow L; Ganguly A
    Hum Mutat; 2006 Jul; 27(7):667-75. PubMed ID: 16752392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.